536 RANIDO Trial: Racotumomab-alum Vaccine, Nimotuzumab or Docetaxel As Switch Maintenance Therapy for Advanced NSCLCM. Hernandez,E. Neninger,E. Santiesteban,R. Ortiz,R. Amador,L. Bello,S. Acosta,Y. Flores,M. Cala,O. Martinez, A. Calana, G. Pichs,M. Robaina,L. Sanchez,C. Viada,A. Valdez,I. Mendoza,P. Guerra,T. CrombetEuropean journal of cancer(2015)引用 0|浏览29暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要